“ANALISIS KEUANGAN CR, PER, ROE, DER, DAN EVA DAN PENGARUHNYA TERHADAP RETURN SAHAM PADA INDUSTRI FARMASI “ (STUDI BURSA EFEK INDONESIA 2008– 2011)

IRAWAN, NURMAN (2013) “ANALISIS KEUANGAN CR, PER, ROE, DER, DAN EVA DAN PENGARUHNYA TERHADAP RETURN SAHAM PADA INDUSTRI FARMASI “ (STUDI BURSA EFEK INDONESIA 2008– 2011). S2 thesis, Universitas Negeri Jakarta.

	Text Cover.pdf Download (22kB)
	Text Table_Of_Content.pdf Download (19kB)
	Text Chapter 1.pdf Download (43kB)
	Text Chapter 2.pdf Restricted to Registered users only Download (152kB)
	Text Chapter 3.pdf Download (352kB)
	Text Chapter 4.pdf Restricted to Registered users only Download (143kB)
	Text Chapter 5.pdf Download (17kB)
	Text Bibiliography.pdf Download (19kB)

Abstract

This research was conducted to examine the effect of Current Ratio (CR), Debt to Equity Ratio (DER), Return On Asset (ROE), Price Earning Ratio (PER) and Economic Value Added (EVA) to share return of pharmaceutical companies that were listed in Indonesia Stock Exchange period 2008-2011. The sampling technique used was purposive sampling with criteria (1) Pharmaceutical companies has complete financial data during the period 2008-2011. (2) Pharmaceutical companies had reported interest expenses in their financial report (3) Pharmaceutical companies listed consecutively on Indonesian Share Exchange in 2008-2011. Based on these criteria 9 samples obtained from the Indonesian Share Exchange sub sector pharmaceutical industries. Data collected from Indonesian Capital Market Directory (ICMD). The analysis technique used is multiple linear regression analysis panel data method, using t-test to test the effect of dependent variables to independent variables partially. It also made the classic assumption test covering heteroskedasticity test . In this research,have shown that CR and EVA have significant impact to the pharmaceutical stock return. But the reslut show that PER, ROE and DER have not a significant influence to the pharmaceutical stock return. Simultaneous of F-test of CR, DER, PER, ROE, and EVA have not significant influence on the pharmaceutical company’s stock return. T-test of CR is 2.78 > T-table (2.447), T-test of PER is -0.151471 < T-table (2.447), T-test of ROE is -8.698011 < T-table (2.447), T-test of DER is 0.092 < T-table (2.447) and T-test of EVA is 2.4892 > T-table (2.447). And F test is 0.140692 > 0.05 with R² is about 0.23. All of above variables have no significance influence to share return of pharmaceutical companies which has listed in Indonesian Stock Exchange during 2008 – 2011.

Actions (login required)

View Item